page_banner

Products

Solifenacin succinate CAS: 242478-38-2

Short Description:

Catalog Number: XD94334
Cas: 242478-38-2
Molecular Formula: C27H32N2O6
Molecular Weight: 480.56
Availability: In Stock 
Price:  
Prepack:  
Bulk Pack: Request Quote

 


Product Detail

Product Tags

Catalog Number XD94334
Product Name Solifenacin succinate
CAS 242478-38-2
Molecular Formula C27H32N2O6
Molecular Weight 480.56
Storage Details Ambient

 

Product Specification

Appearance White powder
Assay 99% min

 

Solifenacin succinate is a medication primarily used for the treatment of overactive bladder (OAB) syndrome. OAB is a common condition characterized by frequent and urgent urination, with or without incontinence. Solifenacin succinate belongs to a class of drugs called antimuscarinics, which work by blocking the action of acetylcholine in the bladder, thereby relaxing the muscles and reducing bladder contractions.The main purpose of solifenacin succinate is to alleviate the symptoms associated with OAB, including urinary frequency, urgency, and nocturia (waking up at night to urinate). By reducing the bladder muscle contractions and increasing bladder capacity, solifenacin succinate helps improve control over bladder function and reduces urinary urgency and frequency.Solifenacin succinate is available in tablet form and is generally taken orally once a day. The dosage may vary depending on the severity of the symptoms and the patient's response. It is important to follow the prescribed dosage and instructions provided by the healthcare provider.Apart from OAB, solifenacin succinate may also be used for other medical conditions, such as neurogenic detrusor overactivity (NDO), which is a type of bladder dysfunction resulting from spinal cord injury or neurological disorders. It can help manage the urinary symptoms associated with NDO, including incontinence and increased urinary frequency.As with any medication, solifenacin succinate may have potential side effects. Common side effects include dry mouth, constipation, dry eyes, blurred vision, drowsiness, and indigestion. These side effects are usually mild and temporary, but if they persist or worsen, it is important to inform a healthcare provider.It is worth noting that solifenacin succinate should be used with caution in patients with certain medical conditions, such as narrow-angle glaucoma, urinary retention, severe liver or kidney impairment, or a history of gastrointestinal obstruction. It is also important to disclose all other medications being taken to avoid any potential drug interactions.In conclusion, solifenacin succinate is a medication used to treat overactive bladder syndrome, providing relief from symptoms of urinary urgency and frequency. By blocking the action of acetylcholine in the bladder, it helps relax the bladder muscles and improve control over bladder function. However, it is essential to use solifenacin succinate as directed by a healthcare provider and to be aware of any potential side effects or contraindications.


  • Previous:
  • Next:

  • Close

    Solifenacin succinate CAS: 242478-38-2